• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    K

    Khulna Medical College

    EST. 1992
    253论文总数
    1,507引用总数

    The Khulna Medical College (KMC) (Bengali: খুলনা মেডিকেল কলেজ) is a government medical school in Khulna, Bangladesh. It is affiliated with Sheikh Hasina Medical University. It is located in the city of Khulna, near the inter-district Bus Stand at the entrance to the city.Khulna Medical College was established in 1992. The current principal is Md Abdul Ahad.

    论文量&引用量时间轴

    机构学者

    排序
    Choudhury Habibur Rasul
    Choudhury Habibur Rasul
    Department of Paediatrics, Khulna Medical College and Hospital
    论文:15引用:0H-index:0
    Akm Mamunur Rashid
    Akm Mamunur Rashid
    Khulna Medical College
    论文:9引用:0H-index:0
    Prof.Dr. Md. Abdul Ahad
    Prof.Dr. Md. Abdul Ahad
    College of Pharmacy, King Saud University
    论文:7引用:0H-index:0
    Mondal D K
    Mondal D K
    Department of Anatomy, Khulna Medical College
    论文:6引用:0H-index:0
    S N Karim
    S N Karim
    Khulna Medical College
    论文:6引用:0H-index:0
    Razia Sultana Sumi
    Razia Sultana Sumi
    Department of Botany;University of Dhaka;Department of Botany, University of Dhaka
    论文:4引用:0H-index:0
    Ahasan H A
    Ahasan H A
    Department of Medicine, Rajshahi Medical College
    论文:4引用:0H-index:0
    Shamima Akhter
    Shamima Akhter
    Khulna Medical College
    论文:4引用:0H-index:0
    Baishakhi Islam
    Baishakhi Islam
    Khulna Medical College
    论文:4引用:0H-index:0

    论文(253)

    年份
    起
    –
    止
    排序
    1Impact of Empagliflozin on Liver Fat Reduction in Type 2 Diabetes and NAFLD: A Systematic Review and Meta-Analysis
    Muhammad Umais, Hooriah Imtiaz, Muhammad Luqman, Sidra Anwar, Muhammad Umer Iftikhar, Kanwal Maheshwari, Zarine Tasnim Sara, Noor ul Huda Naseem, Firose Afra Ibnath, Abdul Rehman Shah Syed, Muhammad Ali Muzammil

    Non-alcoholic fatty liver disease (NAFLD) and type 2 Diabetes Mellitus are the major causes of significant mortality and morbidity. NAFLD and type 2 diabetes have common risk factors. SGLT-2 inhibitors are believed to have a beneficial effect on liver fat in patients with NAFLD and type 2 diabetes. However, there are limited data available on this aspect of empagliflozin use. Thus, we aimed to compare the impact of empagliflozin on liver fat reduction in type 2 diabetes and NAFLD. A comprehensive search of databases like PubMed, Google Scholar, and Cochrane Library was done. In the end, a detailed analysis was performed on a total of 6 finalized studies, all of which were randomized controlled trials. This comprehensive analysis consisted of a cohort of 589 Individuals. A total of six studies were included. Primary outcomes assessed were MRI-PDFF, AST, ALT, HOMA-IR and total bilirubin. Empagliflozin significantly reduced liver fat compared to placebo, with a pooled standardized mean difference (SMD) of −0.43 (95

    2026Endocrine(2026)
    引用
    AI阅读
    加入学术空间
    2Young Onset of Hypertension As a Consequence of Interrupted Descending Thoracic Aorta with Intercostal Collaterals: A Rare Case Report
    Md. Deluwar Hussen, Nazia Ferdoush Supti, Marhama Sadia Seen, Anisur Rahman, Md Asif Umar Patwary, Musarrat Tasnia, MD MAHFUZUR RAHMAN ZEEHAD
    2026
    引用
    AI阅读
    加入学术空间
    3Sex-specific Association of Meal Frequency, Dinner Time, Dinner-to-Sleep Interval, and Sleep Duration at Night on Glucometabolic Control in People with Type 2 Diabetes Mellitus
    Md Rakibul Hasan, Choman Abdullah Mohana, Kishore Kumar Shil, Shahed Morshed, Kaniz Fatema Yeasna

    A bstract Background: Effects of meal- and sleep-related factors on glucometabolic control among South-Asian people with type 2 diabetes mellitus (T2DM) were inadequately reported, especially in the context of sex. Objective: This study evaluated the sex-specific associations of meal- and sleep-related factors on glucometabolic control among people with T2DM. Materials and Methods: From February to December 2025, we enrolled 694 adults with T2DM across four hospitals. Data collection included meal- and sleep-related histories, physical measurements (height, weight, waist circumference, and blood pressure [BP]), and glucometabolic parameters (e.g., glycated hemoglobin, plasma glucose, fasting lipid profiles, and body indices). Findings were categorized and evaluated against established clinical recommendations to identify abnormal health values. Results: Obesity and dyslipidemia were more frequent in females compared with males. More than three daily meals were associated with higher odds for hypertriglyceridemia (odds ratio [OR] = 2.0) in males but lower odds for low high-density lipoprotein-cholesterol (OR = 0.4) in females. Bedtime after 11 pm was associated with higher odds for general (OR = 2.1) and central obesity (OR = 1.9) only in males. Dinner–bedtime interval up to 2 h was associated with higher odds for high total cholesterol (TC), both for males (OR = 2.4) and females (OR = 1.8), and uncontrolled systolic BP (OR = 1.7) in females. Sleep duration at night below 6 h was associated with higher odds for uncontrolled diastolic BP (OR = 2.8) and overall uncontrolled BP (OR = 2.5) in males, and higher odds for high TC (OR = 1.7) in females. Conclusion: Meal- and sleep-related factors may be associated with poor glucometabolic status with distinctive sex-specific association in people with T2DM.

    2026Bangladesh Journal of Endocrinology and Metabolism(2026)
    引用
    AI阅读
    加入学术空间
    4A Case Report of Cardiac Amyloidosis Causing Progressive Heart Failure in a 50 Years Old Bangladeshi Woman
    Md. Zakir Hossen, Jahanara Islam, Asma Akter Rubi, Nusrat Jahan, Prianka Saha, Nusrat Zarin, Md. Deluwar Hussen, Khaleda Parvin

    Cardiac amyloidosis is underdiagonosed under diagnosed and can cause progressive heart failure. This results in progressive ventricular stiffening, loss of diastolic filling, arrhythmias, and eventually heart failure. Early diagnosis is important because newer disease-modifying therapies and optimized heart failure management can lead to better outcomes for the patient. A 50-year-old Bangladeshi female with a new diagnosis of type-2 diabetes mellitus reported a six-month history of progressive shortness of breath with exertion that was currently NYHA class III. She also complained of occasional paroxysmal nocturnal dyspnea, chronic dry cough, generalized swelling and unintentional weight loss. No pallor or jaundice. Pulse rate 88 beat/min, blood pressure 102/64 mmHg, respiration rate 16 breath/min, bibasilar crackles on lung auscultation, shifting dullness, ascites perhaps, tender hepatomegaly. There were no other abnormal systemic findings. In such scenarios, where endomyocardial biopsy and modern genetic analysis are not feasible, clinical acumen and traditional non-invasive imaging features (like echocardiographic apical sparing and cardiac MRI late gadolinium enhancement) will play a crucial role in early diagnosis. One important lesson is that conventional heart failure treatment regimens should be used with great caution in restrictive cardiomyopathies, and easily accessible disease-specific therapies are needed.

    2026Medical Reports(2026)
    引用
    AI阅读
    加入学术空间
    5N-acetylcysteine: Impact on Psychiatric Disorders
    Sadia Binte Anwar Sonia, Muhammad Nurul Alam Siddiki, Sarmin Sultana, Iftekhar Hossain Chowdhury, Susmita Sinha, Miral Mehta,Mainul Haque

    N-acetylcysteine (NAC) is becoming more and more popular medication in the management of mental health conditions. NAC antiinflammatory, antioxidant and glutamate transmission properties, currently being explored for the therapeutic intervention of neurological conditions, e.g. anxiety, depressive disorders, post-traumatic stress disorder, obsessive-compulsive disorders, bipolar disorders and schizophrenia. Clinical studies for many psychiatric diseases have yielded contradictory findings, despite the fact that there is a wealth of preliminary data and intellectual support for the application of NAC in the treatments of many of these illnesses. The most of the research studies have proven insufficient and too briefly explored. More research are required to established NAC efficacy, appropriate indication and adverse drug reactions.

    2026Advances in Human Biology(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 253 篇论文

    合作机构(100)

    Dhaka Medical College and Hospital合作论文 36
    Bangabandhu Sheikh Mujib Medical University合作论文 31
    Rajshahi Medical College合作论文 19
    Chittagong Medical College合作论文 16
    东西方大学合作论文 9
    Sylhet MAG Osmani Medical College合作论文 8
    Dhaka Community Hospital Trust合作论文 7
    Shaheed Suhrawardy Medical College合作论文 7
    Mymensingh Medical College Hospital合作论文 6
    National Institute of Cardiovascular Diseases合作论文 6

    机构统计